BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6277809)

  • 1. Syngeneic and allogeneic cell-mediated cytotoxicity against Marek's disease lymphoblastoid tumor cell lines.
    Schat KA; Shek WR; Calnek BW; Abplanalp H
    Int J Cancer; 1982 Feb; 29(2):187-94. PubMed ID: 6277809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of lymphocytes from chickens with Marek's disease (MD) to MD tumour cell lines.
    Dambrine G; Coudert F; Cauchy L
    IARC Sci Publ (1971); 1978; (24 Pt 2):857-62. PubMed ID: 221408
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated cytotoxic response to cells bearing Marek's disease tumor-associated surface antigen in chickens infected with Marek's disease virus.
    Sharma JM; Coulson BD
    J Natl Cancer Inst; 1977 Jun; 58(6):1647-51. PubMed ID: 68120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of antiviral and antitumor immunity in resistance to Marek's disease.
    Powell PC; Rowell JG
    J Natl Cancer Inst; 1977 Sep; 59(3):919-24. PubMed ID: 197249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cell-mediated immunity to Marek's disease tumor cells in chickens inoculated with Marek's disease vaccines.
    Sharma JM; Witter RL; Coulson BD
    J Natl Cancer Inst; 1978 Nov; 61(5):1273-80. PubMed ID: 213610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantable Marek's disease lymphomas. III. Induction of MHC-restricted tumor immunity by lymphoblastoid cells in F1 hosts.
    DiFronzo NL; Schierman LW
    Int J Cancer; 1989 Sep; 44(3):474-6. PubMed ID: 2550373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells.
    Uni Z; Pratt WD; Miller MM; O'Connell PH; Schat KA
    Vet Immunol Immunopathol; 1994 Dec; 44(1):57-69. PubMed ID: 7725630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cell-mediated immune responses to Marek's disease virus in two chicken lines with defined major histocompatibility complex antigens.
    Garcia-Camacho L; Schat KA; Brooks R; Bounous DI
    Vet Immunol Immunopathol; 2003 Oct; 95(3-4):145-53. PubMed ID: 12963275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a Marek's disease transplantable tumor in inbred line 72 chickens homozygous at the major (B) histocompatibility locus.
    Stephens EA; Witter RL; Nazerian K; Sharma JM
    Avian Dis; 1980; 24(2):358-74. PubMed ID: 6254488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of histocompatibility antigens in cell-mediated cytotoxicity against Marek's disease tumour-derived lymphoblastoid cell lines.
    Powell PC; Mustill BM; Rennie M
    Avian Pathol; 1983 Oct; 12(4):461-8. PubMed ID: 18766805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature of genetic resistance to Marek's disease in chickens.
    Lee LF; Powell PC; Rennie M; Ross LJ; Payne LN
    J Natl Cancer Inst; 1981 Apr; 66(4):789-96. PubMed ID: 6262555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface antigens on Marek's disease lymphoblastoid tumor cell lines.
    Schat KA; Chen CL; Shek WR; Calnek BW
    J Natl Cancer Inst; 1982 Sep; 69(3):715-20. PubMed ID: 6955560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vaccination for Marek's disease on growth of a Marek's-virus-induced transplantable lymphoma in syngeneic and allogeneic chickens.
    Schierman LW; McBride RA
    Avian Dis; 1979; 23(1):47-56. PubMed ID: 486007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).
    Nazerian K; Stephens EA; Sharma JM; Lee LF; Gailitis M; Witter RL
    Avian Dis; 1977; 21(1):69-76. PubMed ID: 190995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of thymic hormone on cell-mediated and humoral immune responses in Marek's disease.
    Quere P; Dambrine G; Bach MA
    Vet Microbiol; 1989 Jan; 19(1):53-64. PubMed ID: 2538023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of genetic resistance to Marek's disease in chickens.
    Powell PC; Lee LF; Mustill BM; Rennie M
    Int J Cancer; 1982 Feb; 29(2):169-74. PubMed ID: 6277808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of anti-tumoral cell-mediated cytotoxicity during the course of Marek's disease in chickens.
    Queré P; Dambrine G
    Ann Rech Vet; 1988; 19(3):193-201. PubMed ID: 3190140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
    Omar AR; Schat KA
    Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantable Marek's disease lymphomas. II. Variable tumor immunity induced by different lymphoblastoid cells.
    Schierman LW
    J Natl Cancer Inst; 1984 Aug; 73(2):423-8. PubMed ID: 6589434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.